Diphtheria D004165

Diseases [C] » Infections [C01] » Bacterial Infections and Mycoses » Bacterial Infections » Gram-Positive Bacterial Infections » Actinomycetales Infections » Corynebacterium Infections » Diphtheria

Description

A localized infection of mucous membranes or skin caused by toxigenic strains of CORYNEBACTERIUM DIPHTHERIAE. It is characterized by the presence of a pseudomembrane at the site of infection. DIPHTHERIA TOXIN, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects.   MeSH

Hierarchy View

View MeSH Tree View ICD-10 Tree

Approved Indicated Drugs (6)

diphtheria, tetanus, and poliovirus vaccine

diphtheria toxoid

diptheria vaccine, toxin/antitoxin mixtures (tat)

erythromycin (ilosone)

procaine benzylpenicillin (novocaine)

sulfadimethoxine

Phase 4 Indicated Drugs (16)

acellular pertussis vaccine (including diptheria and tetanus toxoids) (Tripedia)

attenuated measles vaccine - Edmonston strain (rubeovax)

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine (Kinrix)

diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine (Pediarix)

diphtheria, tetanus and whole cell pertussis vaccine (Boostrix)

haemophilus influenzae type b conjugate vaccine (HibTITER)

hepatitis a vaccine, inactivated (vaqta)

hepatitis b vaccine (recombinant) (Recombivax)

Inactivated polio virus - Enhanced (IPOL)

Meningococcal (Groups A, C, Y, W) Conjugate Vaccine (MenQuadfi)

pneumococcal 13-valent conjugate vaccine (prevnar 13)

quinvaxem

technetium tc-99m pentetate kit (renotec)

Tetanus and diphtheria toxoids adsorbed (Decavac)

tetanus toxoid

trianrix

Phase 3 Indicated Drugs (23)

10-valent Pneumococcal Conjugate Vaccine (Pneumosil)

acellular pertussis vaccine (ACEL-IMUNE\T)

Bivalent group A and C meningococcal vaccine (Menomune-A/C)

bivalent oral polio vaccine (bopv), type 1 and type 3 (BOPV)

diphtheria-tetanus-whole cell pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine

glyco-conjugate neisseria meningitidis serogroup c vaccine

haemophilus influenzae type b-neisseria meningitidis serogroups c and y-tetanus-toxoid conjugate vaccine

hib-menac

human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil)

human rotavirus, live attenuated (Rotarix)

inactivated influenza vaccine

live attenuated varicella vaccine (Varivax)

measles, mumps, and rubella vaccine (MMR)

Measles, Mumps and Rubella Vaccine, Live (Priorix)

measles, mumps, rubella, varicella vaccine (ProQuad)

meningococcal conjugate vaccine (Menveo)

menitorix

Monovalent group C meningococcal vaccine (Menomune-C)

pneumococcal 7-valent conjugate vaccine (Prevnar)

polio, inactivated poliovirus vaccine (Salk Vaccine)

polyribosil-ribitol-phosphate vaccine

rotavirus vaccine, live, oral, pentavalent (Rotateq)

tritanrix-hepb

Phase 2 Indicated Drugs (7)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23)

aluminum hydroxide (Gaviscon)

gc3111

gsk2036874a

menjugate

multi-valent pneumococcal conjugate vaccine

polysaccharide diphtheria toxoid conjugate vaccine

Phase 1 Indicated Drugs (2)

s315

sodium chloride


Organization Involved with Phase 4 Indications (25)

Aarhus University

Bandim Health Project

Crucell

Danish Council for Development Research

Department of Health, United Kingdom

GlaxoSmithKline

Government of Norway

Harvard University

Institute of Arthritis Research

Korea University

Leiden University

LG

Louisiana State University

Medical Research Council, The Gambia

National Institute of Allergy and Infectious Diseases (NIAID)

Novo Nordisk

Public Health England

Sanofi

Sanofi-Aventis

Shantha Biotechnics Limited

Statens Serum Institut

Swedish Institute for Infectious Disease Control

Tel Aviv University

University of Copenhagen

University of London

Organization Involved with Phase 3 Indications (10)

Boryung Pharmaceutical Company

Catholic University of Korea

Eulji University

Government of China

Government of Vietnam

Institut Pasteur

Mitsubishi Tanabe

Novartis

Osaka University

Universidad Autonoma de Barcelona

Organization Involved with Phase 2 Indications (4)

Chesapeake Research Group, LLC

Green Cross Corporation

IRC Clinics, Towson

JN-International Medical Corporation

Organization Involved with Phase 1 Indications (10)

Axio Research Corporation

Centers for Disease Control and Prevention (CDC)

Emory University

Ghent University

Grifols

Hammond Clinical Trial Consulting, LLC

MassBiologics

Parexel

RMD Insight, LLC

Tianjin Cansino Biotechnology Inc

Organization Involved with Other Experimental Indications (11)

Clifford Craig Medical Research Trust

Johns Hopkins University

Medical University of Warsaw

Monash University

Poznan University

Silesian University of Medicine

The Peter Doherty Institute

University of Sao Paulo

Vabiotech

Vietstar Biomedical Research

Wroclaw Medical University

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.